OssDsign Toekomstige groei
Future criteriumcontroles 2/6
OssDsign is forecast to grow earnings and revenue by 55.9% and 23.9% per annum respectively. EPS is expected to grow by 58.5% per annum. Return on equity is forecast to be -20.7% in 3 years.
Belangrijke informatie
55.9%
Groei van de winst
58.5%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 15.7% |
| Inkomstengroei | 23.9% |
| Toekomstig rendement op eigen vermogen | -20.7% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 23 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 217 | -25 | -28 | -27 | 3 |
| 12/31/2025 | 169 | -42 | -43 | -42 | 4 |
| 12/31/2024 | 124 | -56 | -76 | -75 | 4 |
| 6/30/2024 | 123 | -114 | -91 | -91 | N/A |
| 3/31/2024 | 118 | -118 | -95 | -95 | N/A |
| 12/31/2023 | 112 | -130 | -94 | -94 | N/A |
| 9/30/2023 | 97 | -109 | -93 | -93 | N/A |
| 6/30/2023 | 83 | -95 | -93 | -93 | N/A |
| 3/31/2023 | 71 | -99 | -92 | -92 | N/A |
| 12/31/2022 | 57 | -99 | -86 | -86 | N/A |
| 9/30/2022 | 46 | -96 | -82 | -82 | N/A |
| 6/30/2022 | 38 | -93 | -98 | -98 | N/A |
| 3/31/2022 | 33 | -95 | -90 | -90 | N/A |
| 12/31/2021 | 32 | -94 | -90 | -90 | N/A |
| 9/30/2021 | 29 | -90 | -94 | -93 | N/A |
| 6/30/2021 | 27 | -92 | -77 | -76 | N/A |
| 3/31/2021 | 23 | -90 | -83 | -80 | N/A |
| 12/31/2020 | 25 | -85 | -82 | -79 | N/A |
| 9/30/2020 | 24 | -89 | -81 | -79 | N/A |
| 6/30/2020 | 22 | -89 | -90 | -88 | N/A |
| 3/31/2020 | 22 | -85 | -87 | -86 | N/A |
| 12/31/2019 | 18 | -84 | -87 | -87 | N/A |
| 9/30/2019 | 18 | -72 | -92 | -90 | N/A |
| 6/30/2019 | 20 | -66 | -79 | -75 | N/A |
| 3/31/2019 | 21 | -62 | -83 | -78 | N/A |
| 12/31/2018 | 21 | -56 | -74 | -66 | N/A |
| 12/31/2017 | 16 | -63 | N/A | -41 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 5J6 is forecast to remain unprofitable over the next 3 years.
Winst versus markt: 5J6 is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: 5J6 is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: 5J6's revenue (23.9% per year) is forecast to grow faster than the German market (5.5% per year).
Hoge groei-inkomsten: 5J6's revenue (23.9% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: 5J6 is forecast to be unprofitable in 3 years.